| 英文名稱 |
中文名稱 |
CAS號 |
操作 |
| Vildagliptin Impurity 1/Vildagliptin Diketo Impurity/Vildagliptin Lactam/2-((1r,3s,5R,7S)-3-hydroxyadamantan-1-yl)hexahydropyrrolo[1,2-a]pyrazine-1,4-dione |
維格列汀雜質(zhì) |
1789703-36-1 |
詳細(xì)
|
| Rabeprazole impurity 2/Rabeprazole EP Impurity D/2-(((1H-benzo[d]imidazol-2-yl)sulfinyl)methyl)-4-(3-methoxypropoxy)-3-methylpyridine 1-oxide |
雷貝拉唑雜質(zhì)A |
924663-38-7 |
詳細(xì)
|
| Omeprazole impurity 4/Omeprazole EP Impurity D/Omeprazole Sulfone/5-Methoxy-2-[[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulphonyl]-1H-benzimidazole |
奧美拉唑雜質(zhì)A |
88546-55-8 |
詳細(xì)
|
| Omeprazole impurity 3/Omeprazole EP Impurity B/4-Desmethoxy Omeprazole/2-[(RS)-[(3,5-Dimethylpyridin-2-yl)methyl]sulphinyl]-5-methoxy-1H-benzimidazole |
埃索美拉唑雜質(zhì)B |
110374-16-8 |
詳細(xì)
|
| Prasugrel impurity 4/Prasugrel Chlorobutyryl Analog/5-(5-chloro-1-(2-fluorophenyl)-2-oxopentyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl acetate |
開環(huán)普拉格雷 |
1056459-37-0 |
詳細(xì)
|
| Selexipag impurity 3/2,3-dichloro-5,6-diphenylpyrazine |
賽樂西帕雜質(zhì)3 |
57038-62-7 |
詳細(xì)
|
| Vildagliptin Impurity 9/(S)-1-(2-Chloro-acetyl)-pyrrolidine-2-carboxylic acid |
維格列汀雜質(zhì) |
23500-10-9 |
詳細(xì)
|
| Rabeprazole impurity 15/(S)-O-Desmethyl Rabeprazole Impurity/(S)-3-((2-(((1H-benzo[d]imidazol-2-yl)sulfinyl)methyl)-3-methylpyridin-4-yl)oxy)propan-1-ol |
(S)-O-脫甲基雷貝拉唑雜質(zhì) |
179952-05-7 |
詳細(xì)
|
| Vildagliptin Impurity 14/(R)-Vildagliptin/(R)-1-(((1r,3S,5R,7S)-3-hydroxyadamantan-1-yl)glycyl)pyrrolidine-2-carbonitrile |
維格列汀雜質(zhì) |
1036959-27-9 |
詳細(xì)
|
| Omeprazole impurity 9/Omeprazole EP Impurity I/Omeprazole Sulfone N-Oxide/5-Methoxy-2-[[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulphonyl]-1H-benzimidazole N-Oxide |
埃索美拉唑雜質(zhì)I |
158812-85-2 |
詳細(xì)
|
| Vortioxetine impurity 2/1-CHLORO-2-NITROSO-BENZENE |
沃替西汀雜質(zhì)12 |
932-33-2 |
詳細(xì)
|
| Tedizolid impurity 10/(S)-Tedizolid/(S)-3-(3-fluoro-4-(6-(2-Methyl-2H-tetrazol-5-yl)pyridin-3-yl)phenyl)-5-(hydroxyMethyl)oxazolidin-2-one |
泰地唑胺雜質(zhì) A |
1431699-67-0 |
詳細(xì)
|
| Parecoxib impurity 1/N-((3-(5-methyl-3-phenylisoxazol-4-yl)phenyl)sulfonyl)propionamide |
間位帕瑞昔布 |
1709956-89-7 |
詳細(xì)
|
| Levosimendan impurity 6/Acetamide,N-[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]-, (R)- |
|
39052-02-1 |
詳細(xì)
|
| Tedizolid impurity 13/(S)-(3-(3-fluoro-4-(6-(2-methyl-2H-tetrazol-5-yl)pyridin-3-yl) phenyl)-2-oxooxazolidin-5-yl)methyl dihydrogen phosphate |
特地唑胺雜質(zhì)3 |
1835340-19-6 |
詳細(xì)
|
| Vortioxetine impurity 3/N-(2-chlorophenyl)hydroxylamine |
2-氯苯基羥胺 |
10468-16-3 |
詳細(xì)
|
| Vortioxetine impurity 1/N,N-Dimethyl-2-nitroaniline |
N,N-二甲基-3-硝基苯胺 |
610-17-3 |
詳細(xì)
|
| Tedizolid impurity 14/Diphosphoric acid P,P'-bis[[(5R)-3-[3-fluoro-4-[6-(2-methyl-2H-tetrazol-5-yl)-3-pyridinyl]phenyl]-2-oxo-5-oxazolidinyl]methyl] ester |
特地唑胺雜質(zhì)16 |
1220910-90-6 |
詳細(xì)
|
| Tedizolid impurity 12/(R)-5-(chloromethyl)-3-(3-fluoro-4-(6-(2-methyl-2H-tetrazol-5-yl)pyridin-3-yl)phenyl)oxazolidin-2-one |
(R)-5-(chloromethyl)-3-(3-fluoro-4-(6-(2-methyl-2H-tetrazol-5-yl)pyridin-3-yl)phenyl)oxazolidin-2-one |
1239662-46-4 |
詳細(xì)
|
| Racecadotril impurity 6/Racecadotril EP Imurity H/dibenzyl 5,10-dibenzyl-4,11-dioxo-7,8-dithia-3,12-diazatetradecanedioate |
消旋卡多曲EP雜質(zhì)H |
141437-88-9 |
詳細(xì)
|
| Cimetidine impurity 9/Cimetidine EP Impurity I HCl/(5-ethyl-1H-imidazol-4-yl)methanol hydrochloride |
西咪替丁EP雜質(zhì)I |
38603-74-6 |
詳細(xì)
|
| Cimetidine impurity 4/Cimetidine EP Impurity D DiHCl/Cimetidine Descyano DiHCl/1-Methyl-3-[2-[[(5-methyl-1Himidazol-4-yl)methyl]sulfanyl]ethyl]guanidine dihydrochloride |
N-甲基-N'-[2-[[(5-甲基-1H-咪唑-4-基)甲基]硫基]乙基]胍二鹽酸鹽 |
59660-24-1 |
詳細(xì)
|
| Cimetidine impurity 1/Cimetidine EP Impurity A/Cimetidine Methylsulfanyl Analog /Methyl 3-cyano-1-[2-[[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl]ethyl] carbamimidothioate |
西咪替丁二縮物 |
52378-40-2 |
詳細(xì)
|
| Cimetidine impurity 10/Cimetidine EP Impurity J DiHCl/2-(((5-methyl-1H-imidazol-4-yl)methyl)thio)ethan-1-amine dihydrochloride |
鹽酸西咪替丁EP雜質(zhì)J |
38603-72-4 |
詳細(xì)
|
| Cimetidine impurity 5/Cimetidine EP Impurity E/Cimetidine Sulfoxide /2-Cyano-1-methyl-3-[2-[[(5-methyl-1H-imidazol-4-yl)methyl]sulfinyl]-ethyl]guanidine ; |
西咪替丁亞砜鹽酸鹽 |
54237-72-8 |
詳細(xì)
|
| Cimetidine impurity 3/Cimetidine EP Impurity C/Cimetidine Amide Impurity/1-[(Methylamino)-[[2-[[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl]-ethyl] amino]methylidene]urea |
西咪替丁EP雜質(zhì)C |
77076-18-7 |
詳細(xì)
|
| Racecadotril impurity 4/Racecadotril EP Imurity F/benzyl [(2-benzylprop-2-enoyl)amino]acetate |
消旋卡多曲雜質(zhì)F |
87428-99-7 |
詳細(xì)
|
| Racecadotril impurity 2/Racecadotril EP impurity C/[[(2RS)-2-[(acetylsulfanyl)methyl]-3-phenylpropanoyl]amino]acetic acid |
消旋卡多曲雜質(zhì)C |
124735-06-4 |
詳細(xì)
|
| Racecadotril impurity 7/Racecadotril Diacid Impurity/3,3-Disulfanediylbis(2-benzylpropanoic acid) |
消旋卡多曲二元酸雜質(zhì) |
141437-87-8 |
詳細(xì)
|
| Racecadotril impurity 3/Racecadotril EP impurity D/5,10-dibenzyl-4,11-dioxo-7,8-dithia-3,12-diazatetradecanedioic acid |
消旋卡多曲雜質(zhì)D |
123658-06-0 |
詳細(xì)
|
| ZolpidemEPImpurityA |
唑吡坦EP雜質(zhì)A |
1346600-85-8 |
詳細(xì)
|
| Rupatadine impurity 1/Rupatadine N-Oxide/3-((4-(8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)piperidin-1-yl)methyl)-5-methylpyridine 1-oxide |
盧帕他定雜質(zhì)7 |
1704730-21-1 |
詳細(xì)
|
| Sorafenib impurity 2/Deschloro Sorafenib/N-Methyl-4-[4-[[[[3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-2-pyridinecarboxamide |
索拉非尼雜質(zhì) 6 |
1285533-84-7 |
詳細(xì)
|
| Safinamide impurity 1/(S)-2-((4-(benzyloxy)benzyl)amino)propanamide |
沙芬酰胺雜質(zhì)04 |
133865-32-4 |
詳細(xì)
|
| Safinamide impurity 5/(S)-2-((3-((3-fluorobenzyl)oxy)benzyl)amino)propanamide |
沙芬酰胺雜質(zhì)08 |
861398-52-9 |
詳細(xì)
|
| Erlotinib impurity 7/Erlotinib Carboxylic Acid/-(3-((6,7-bis(2-methoxyethoxy)quinazolin-4-yl)amino)phenyl)acetic acid |
厄洛替尼雜質(zhì) |
882420-21-5 |
詳細(xì)
|
| Erlotinib impurity 10/N-(3-bromophenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine |
埃羅替尼雜質(zhì)3 |
328528-74-1 |
詳細(xì)
|
| Erlotinib impurity 21/6-(2-chloroethoxy)-N-(3-ethynylphenyl)-7-(2-methoxyethoxy)quinazolin-4-amine |
厄洛替尼雜質(zhì) |
183321-83-7 |
詳細(xì)
|
| Sorafenib impurity 13/Sorafenib Urea Impurity/N-methyl-4-(4-ureidophenoxy)picolinamide |
替卡格雷 |
1129683-88-0 |
詳細(xì)
|
| Vildagliptin Impurity 20 |
維格列汀雜質(zhì) |
565453-41-0 |
詳細(xì)
|
| Sorafenib impurity 1/ethyl (4-chloro-3-(trifluoromethyl)phenyl)carbamate |
索拉非尼相關(guān)物質(zhì)2 |
18585-06-3 |
詳細(xì)
|
| Sorafenib impurity 7/Methyl 4-(Methylamino)picolinate |
索拉非尼雜質(zhì) |
1256817-30-7 |
詳細(xì)
|
| Sorafenib impurity 8/1-(4-Chloro-3-(trifluoromethyl)phenyl)urea |
N-[4-氯-3-(三氟甲基)苯基]脲 |
343247-69-8 |
詳細(xì)
|
| Omeprazole impurity 11/Omeprazole N-Methyl 5-Methoxy Analog/5-Methoxy-2-(((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)sulfinyl)-1-methyl-1H-benzo[d]imidazole |
埃索美拉唑雜質(zhì)H193/61 |
89352-76-1 |
詳細(xì)
|
| Sorafenib impurity 5/6-Chloro-N-methylpyridine-2-carboxamide |
6-氯-N-甲基2-吡啶甲酰胺 |
845306-04-9 |
詳細(xì)
|
| Fasudil impurity 9/N,N'-Bis(ethylene)-p-Toluenesulfonamide |
N,N'-二苯磺?；叶?/td>
| 4403-78-5 |
詳細(xì)
|
| Prasugrel impurity 2/Prasugrel Para-Fluoro Isomer/5-(2-cyclopropyl-1-(4-fluorophenyl)-2-oxoethyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl acetate |
普拉格雷雜質(zhì)III |
1391194-50-5 |
詳細(xì)
|
| Tedizolid impurity 11/6,6'-bis(2-methyl-2H-tetrazol-5-yl)-3,3'-bipyridine |
特地唑胺雜質(zhì)41 |
2095840-91-6 |
詳細(xì)
|
| Vildagliptin Impurity 16/Vildagliptin Chloroacetyl Nitrile (S)-Isomer/(2S)-1-(Chloroacetyl)-2-Pyrrolidinecarbonitrile |
維格列汀雜質(zhì) |
207557-35-5 |
詳細(xì)
|
| Rabeprazole impurity 16/(R)-O-Desmethyl Rabeprazole Impurity/(R)-3-((2-(((1H-benzo[d]imidazol-2-yl)sulfinyl)methyl)-3-methylpyridin-4-yl)oxy)propan-1-ol |
(R)-O脫甲基雷貝拉唑雜質(zhì) |
179952-04-6 |
詳細(xì)
|
| Rabeprazole impurity 3/Rabeprazole EP Impurity E/4-Methoxy Rabeprazole/4-Desmethoxypropoxyl-4-Methoxy Rabeprazole ; 2-[[(4-Methoxy-3-methyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole |
雷貝拉唑4-甲氧基雜質(zhì) |
102804-77-3 |
詳細(xì)
|
| Rabeprazole impurity 8/2-(((4-(3-chloropropoxy)-3-methylpyridin-2-yl)methyl)sulfinyl)-1H-benzo[d]imidazole |
雷貝拉唑雜質(zhì)8 |
1613482-73-7 |
詳細(xì)
|
| Rabeprazole impurity 5/Lansoprazole EP Impurity F Sulfide/4-Desmethoxypropoxyl-4-Chloro Rabeprazole Sulfide/2-[(RS)-[(4-Chloro-3-methylpyridin-2-yl)methyl]sulphinyl]-1H-benzimidazole |
2-(4-氯-3-甲基-2-吡啶基甲硫基)-1H-苯并咪唑 |
103312-62-5 |
詳細(xì)
|
| Rabeprazole impurity 4/Rabeprazole EP Impurity G/Rabeprazole Sulfide 4-Methoxy Analog/2-[[(4-Methoxy-3-methyl-2-pyridinyl)methyl]sulfanyl]-1H-benzimidazole |
雷貝拉唑雜質(zhì) |
102804-82-0 |
詳細(xì)
|
| Safinamide impurity 2/(S)-2-((4-((4-fluorobenzyl)oxy)benzyl)amino)propanamide |
沙芬酰胺雜質(zhì)05 |
202825-43-2 |
詳細(xì)
|
| Safinamide impurity 3/(S)-2-((4-((2-fluorobenzyl)oxy)benzyl)amino)propanamide |
沙芬酰胺雜質(zhì) |
133865-88-0 |
詳細(xì)
|
| Rabeprazole impurity 6/Rabeprazole EP Impurity I/Rabeprazole Sulfone N-Oxide/2-[[[4-(3-Methoxypropoxy)-3-methyl-1-oxido-2-pyridinyl] methyl]sulfonyl]-1H-benzimidazole |
雷貝拉唑砜 N-氧化物 |
924663-37-6 |
詳細(xì)
|
| Lansoprazole impurity 4/Lansoprazole EP Impurity F/Rabeprazole Chloro Analog (USP)/Rabeprazole EP Impurity H/2-(((4-Chloro-3-methylpyridin-2-yl)methyl)sulfinyl)-1H-benzo[d]imidazole |
4-氯蘭索拉唑 |
168167-42-8 |
詳細(xì)
|
| Omeprazole impurity 5/Omeprazole EP Impurity E/Omeprazole N-Oxide/4-Methoxy-2-[[(RS)-(5-methoxy-1H-benzimidazol-2-yl)sulfinyl]methyl]-3,5-dimethylpyridine 1-oxide |
奧美拉唑雜質(zhì) |
176219-04-8 |
詳細(xì)
|
| Omeprazole impurity 17/5-Methoxy-1H-benzimidazole-2-sulfonic acid |
5-甲氧基-1H-苯并咪唑-2-磺酸 |
106135-28-8 |
詳細(xì)
|
| Prasugrel impurity 3/5-(2-cyclopropyl-2-oxo-1-phenylethyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl acetate |
普拉格雷雜質(zhì)1 |
1391194-45-8 |
詳細(xì)
|
| Vildagliptin Impurity 3/Vildagliptin Mono Keto Impurity/Hexahydro-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)-1-imino- pyrrolo[1,2-a]pyraz |
維格列汀雜質(zhì)E |
1789703-37-2 |
詳細(xì)
|
| Vildagliptin Impurity 6/Vildagliptin Dimer Impurity/(2S,2S)-1,1-[[(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)imino]bis(1-oxo-2,1-ethanediyl)]bis[2-Pyrrolidinecarbonitrile] |
維格列汀雜質(zhì) |
1036959-23-5 |
詳細(xì)
|
| Vildagliptin Impurity 8/Vildagliptin Chloroacetyl Amide (S)-Isomer/(S)-1-(2-chloroacetyl)pyrrolidine-2-carboxamide |
維格列汀雜質(zhì) |
214398-99-9 |
詳細(xì)
|
| Vildagliptin Impurity 13/((1r,3s,5R,7S)-3-hydroxyadamantan-1-yl)glycine |
維格列汀雜質(zhì) |
1032564-18-3 |
詳細(xì)
|
| Vildagliptin Impurity 17/Vildagliptin Dipyrrolidine Impurity/octahydro-5H,10H-dipyrrolo[1,2-a:1',2'-d]pyrazine-5,10-dione |
維格列汀雜質(zhì) |
6708-06-1 |
詳細(xì)
|
| Vildagliptin Impurity 15/Vildagliptin Chloroacetyl Nitrile (R)-Isomer/(1S)-2-(2-chloroacetyl)cyclopentane-1-carbonitrile |
維格列汀雜質(zhì) |
565452-98-4 |
詳細(xì)
|
| Prasugrel impurity 1/5-(2-Cyclopropyl-1-(3-fluorophenyl)-2-oxoethyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl acetate |
間氟普拉格雷 |
1391194-39-0 |
詳細(xì)
|
| Fasudil impurity 10 |
1,4-二對甲苯磺?；?1,4-二氮雜環(huán)庚 |
5769-35-7 |
詳細(xì)
|
| Palbociclib impurity 1/1-(2-Chloro-4-(cyclopentylamino)pyrimidin-5-yl)ethan-1-one |
PALBOCICLIB:中間體 |
1244949-62-9 |
詳細(xì)
|
| Sorafenib impurity 20/Sorafenib Hydroxydemethylamine/4-[4-[[[[4-Chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-2-pyridinecarboxylic Acid |
索拉非尼相關(guān)化合物A |
1012058-78-4 |
詳細(xì)
|
| Sorafenib impurity 4/4-Deschloro-2-chloro-Sorafenib/4-(4-(3-(2-chloro-3-(trifluoromethyl)phenyl)ureido)phenoxy)-N-methylpicolinamide |
索拉非尼相關(guān)物質(zhì)8 |
1431697-81-2 |
詳細(xì)
|
| SafinamideImpurity7 |
沙芬酰胺雜質(zhì) |
690969-16-5 |
詳細(xì)
|
| Erlotinib impurity 6/Erlotinib Hydroxy Metabolite/4-Hydroxy Erlotinib/4-((6,7-bis(2-methoxyethoxy)quinazolin-4-yl)amino)-2-ethynylphenol |
厄洛替尼雜質(zhì) |
882420-22-6 |
詳細(xì)
|
| Sorafenib impurity 23/Sorafenib N-Oxide/4-(4-(3-(4-chloro-3-(trifluoromethyl)phenyl)ureido)phenoxy)-2-(methylcarbamoyl)pyridine 1-oxide |
索拉非尼N氧化物 |
583840-03-3 |
詳細(xì)
|
| Erlotinib impurity 9/6-O-Desmethoxyethyl-6-O-chloroethyl Erlotinib Hydrochloride/6-(2-chloroethoxy)-N-(3-ethynylphenyl)-7-(2-methoxyethoxy)quinazolin-4-amine hydrochloride |
厄洛替尼雜質(zhì)2 |
183320-04-9 |
詳細(xì)
|
| Erlotinib impurity 20/7-O-Desmethoxy-7-O-chloroethyl Erlotinib/7-(2-chloroethoxy)-N-(3-ethynylphenyl)-6-(2-methoxyethoxy)quinazolin-4-amine |
厄洛替尼雜質(zhì) |
183321-85-9 |
詳細(xì)
|
| Safinamide impurity 9/(S)-2-[3-(2-fluoro-benzyl)-4-(2-fluoro-benzyloxy)-benzylamino]propanamide |
沙芬酰胺雜質(zhì) |
1000370-28-4 |
詳細(xì)
|
| Vildagliptin Impurity 5/Vildagliptin Carboxylic Acid/(2s)-1-(2-((3-hydroxyadamantan-1-yl)amino)acetyl)pyrrolidine-2-carboxylic acid |
維格列汀雜質(zhì) |
565453-40-9 |
詳細(xì)
|
| Vildagliptin Impurity 7/Vildagliptin Amide Impurity/N-(3-Hydroxytricyclo[3.3.1.13,7]dec-1-yl)glycyl-L-prolinamide |
維格列汀雜質(zhì) |
565453-39-6 |
詳細(xì)
|
| Tedizolid impurity 8/(S)-3-(4-bromo-3-fluorophenyl)-5-(hydroxymethyl)oxazolidin-2-one |
磷酸特地唑胺雜質(zhì) |
1369530-77-7 |
詳細(xì)
|
| Vildagliptin Impurity 10/Methyl (2S)-1-(2-chloroacetyl)pyrrolidine-2-carboxylate |
維格列汀雜質(zhì) |
38074-72-5 |
詳細(xì)
|
| Fasudil impurity 1/Quinoline-5-sulfonic acid |
5-喹啉磺酸 |
23261-58-7 |
詳細(xì)
|
| Selexipag impurity 6/Selexipag Acid/2-{4-[(5,6-diphenylpyrazin-2-yl)(propan-2-yl)amino]butoxy}acetic acid |
[4-[(5,6-二苯基吡嗪基)(1-甲基乙基)氨基]丁氧基]乙酸 |
475085-57-5 |
詳細(xì)
|
| Sorafenib impurity 6/4-Chloro-N,N-dimethylpyridine-2-carboxamide |
4-氯-N,N-二甲基吡啶酰胺 |
114780-06-2 |
詳細(xì)
|
| Omeprazole impurity 18/(R)-Omeprazole/(R)-5-Methoxy-2-(((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)sulfinyl)-1H-benzo[d]imidazole |
(R)-奧美拉唑 |
119141-89-8 |
詳細(xì)
|
| Rupatadine impurity 2/3,5-bis((4-(8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)piperidin-1-yl)methyl)pyridine |
氯雷他定羥基哌N -氧化物 |
1224515-72-3 |
詳細(xì)
|
| Zolpidem impurity 2/N,N-dimethyl-2-(6-methyl-2-(p-tolyl)imidazo[1,2-a]pyridin-3-yl)-2-oxoacetamide |
2-酮佐普利特 |
400038-68-8 |
詳細(xì)
|
| LevothyroxineEPImpurityF |
L-甲狀腺素雜質(zhì)F |
911661-90-0 |
詳細(xì)
|
| Ibrutinib impurity 3/
3-(4-Phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine |
伊布替尼中間體N-2 |
330786-24-8 |
詳細(xì)
|
| Ibrutinib impurity 7/(R)-N-Desacryloyl N-Propionyl Ibrutinib/1-[(3R)-3-[4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-1-piperidinyl]-1-propanone |
伊布替尼雜質(zhì)7 |
1839099-22-7 |
詳細(xì)
|
| Ibrutinib impurity 5/(R)-tert-butyl 3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)-piperidine-1-carboxylate |
(R)-3-[4-氨基-3-(4-苯氧基苯基)-1H-吡唑并[3,4-D]嘧啶-1-基]哌啶-1-羧酸叔丁酯 |
1022150-11-3 |
詳細(xì)
|
| Ibrutinib impurity 2/(S)-Ibrutinib/(S)-1-(3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one |
（S）-依魯替尼 |
936563-97-2 |
詳細(xì)
|
| Flucofuron/1,3-Bis(4-chloro-3-(trifluoromethyl)phenyl)urea |
索拉菲尼雜質(zhì) |
370-50-3 |
詳細(xì)
|
| Topiroxostat impurity 4/4-Amino-3,5-bis(4-pyridyl)-1,2,4-triazole |
3,5-雙（吡啶-4-基）-4-氨基-1,2,4-三唑 |
38634-05-8 |
詳細(xì)
|
| 10-Formyl Folic Acid |
10-甲酰葉酸 |
134-05-4 |
詳細(xì)
|
| Safinamide impurity 7/(R)-2-((4-((3-fluorobenzyl)oxy)benzyl)amino)propanamide |
沙芬酰胺對映異構(gòu)體 |
174756-44-6 |
詳細(xì)
|
| Safinamide?Acid |
沙芬酰胺雜質(zhì) |
1160513-60-9 |
詳細(xì)
|
| Solifenacin impurity 1/Solifenacin EP Impurity A/Solifenacin S Isomer/(S)-1-Phenyl-1,2,3,4-tetrahydroisoquinoline |
(S)-1-苯基-1,2,3,4-四氫異喹啉 |
118864-75-8 |
詳細(xì)
|
| Eptifibatide impurity 3/Deamidated Eptifibatide Impurity/(3R,11S,17S,20S,25aS)-20-((1H-indol-3-yl)Methyl)-17-(carboxymethyl)-11-(4-guanidinobutyl)-1,9,12,15,18,21-hexaoxodocosahydro-1H-pyrrolo[2,1-g][1,2,5,8,11,14,17,20]dithiahexaazacyclotricosine-3-carboxylic Acid |
依替巴肽雜質(zhì)17 |
618118-95-9 |
詳細(xì)
|